Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

1.

Epithelial mesenchymal transition traits in human breast cancer cell lines.

Blick T, Widodo E, Hugo H, Waltham M, Lenburg ME, Neve RM, Thompson EW.

Clin Exp Metastasis. 2008;25(6):629-42. doi: 10.1007/s10585-008-9170-6. Epub 2008 May 7. Review.

PMID:
18461285
[PubMed - indexed for MEDLINE]
2.

Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.

Blick T, Hugo H, Widodo E, Waltham M, Pinto C, Mani SA, Weinberg RA, Neve RM, Lenburg ME, Thompson EW.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):235-52. doi: 10.1007/s10911-010-9175-z. Epub 2010 Jun 4. Review.

PMID:
20521089
[PubMed - indexed for MEDLINE]
3.

Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.

Gilles C, Polette M, Birembaut P, Brünner N, Thompson EW.

Clin Exp Metastasis. 1997 Sep;15(5):519-26.

PMID:
9247254
[PubMed - indexed for MEDLINE]
4.

Gene expression profiling to identify genes associated with high-invasiveness in human squamous cell carcinoma with epithelial-to-mesenchymal transition.

Higashikawa K, Yoneda S, Taki M, Shigeishi H, Ono S, Tobiume K, Kamata N.

Cancer Lett. 2008 Jun 18;264(2):256-64. doi: 10.1016/j.canlet.2008.01.045. Epub 2008 Mar 10.

PMID:
18329791
[PubMed - indexed for MEDLINE]
5.

Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.

Wang X, Zheng M, Liu G, Xia W, McKeown-Longo PJ, Hung MC, Zhao J.

Cancer Res. 2007 Aug 1;67(15):7184-93.

PMID:
17671186
[PubMed - indexed for MEDLINE]
Free Article
6.

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J.

Cancer Res. 2008 Feb 15;68(4):989-97. doi: 10.1158/0008-5472.CAN-07-2017.

PMID:
18281472
[PubMed - indexed for MEDLINE]
Free Article
7.

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.

PMID:
19123925
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.

Li GC, Wang ZY.

Anticancer Res. 2006 Sep-Oct;26(5A):3555-60.

PMID:
17094482
[PubMed - indexed for MEDLINE]
Free Article
9.

Expression profiling of epithelial plasticity in tumor progression.

Jechlinger M, Grunert S, Tamir IH, Janda E, Lüdemann S, Waerner T, Seither P, Weith A, Beug H, Kraut N.

Oncogene. 2003 Oct 16;22(46):7155-69.

PMID:
14562044
[PubMed - indexed for MEDLINE]
10.

Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.

Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y.

Cancer Res. 2008 Jul 1;68(13):5104-12. doi: 10.1158/0008-5472.CAN-07-5680.

PMID:
18593909
[PubMed - indexed for MEDLINE]
Free Article
11.

Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway.

Chou TY, Chen WC, Lee AC, Hung SM, Shih NY, Chen MY.

Cell Signal. 2009 May;21(5):704-11. doi: 10.1016/j.cellsig.2009.01.008. Epub 2009 Jan 7.

PMID:
19166932
[PubMed - indexed for MEDLINE]
12.

Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.

Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM.

Stem Cells. 2012 Feb;30(2):292-303. doi: 10.1002/stem.791.

PMID:
22102611
[PubMed - indexed for MEDLINE]
Free Article
13.

Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.

Ghoul A, Serova M, Astorgues-Xerri L, Bieche I, Bousquet G, Varna M, Vidaud M, Phillips E, Weill S, Benhadji KA, Lokiec F, Cvitkovic E, Faivre S, Raymond E.

Cancer Res. 2009 May 15;69(10):4260-9. doi: 10.1158/0008-5472.CAN-08-2837. Epub 2009 May 5.

PMID:
19417139
[PubMed - indexed for MEDLINE]
Free Article
14.

Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).

Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, O'Brien T, Kerin MJ.

Breast Cancer Res Treat. 2010 Nov;124(2):317-26. doi: 10.1007/s10549-010-0734-1. Epub 2010 Jan 20.

PMID:
20087650
[PubMed - indexed for MEDLINE]
15.

The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.

Hollier BG, Evans K, Mani SA.

J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):29-43. doi: 10.1007/s10911-009-9110-3. Epub 2009 Feb 26. Review.

PMID:
19242781
[PubMed - indexed for MEDLINE]
16.

Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.

Lou Y, Preobrazhenska O, auf dem Keller U, Sutcliffe M, Barclay L, McDonald PC, Roskelley C, Overall CM, Dedhar S.

Dev Dyn. 2008 Oct;237(10):2755-68. doi: 10.1002/dvdy.21658.

PMID:
18773493
[PubMed - indexed for MEDLINE]
Free Article
17.

Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells.

Cannito S, Novo E, Compagnone A, Valfrè di Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A, Bozzo F, Cravanzola C, Bravoco V, Colombatto S, Parola M.

Carcinogenesis. 2008 Dec;29(12):2267-78. doi: 10.1093/carcin/bgn216. Epub 2008 Sep 12.

PMID:
18791199
[PubMed - indexed for MEDLINE]
Free Article
18.

Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.

D'Assoro AB, Leontovich A, Amato A, Ayers-Ringler JR, Quatraro C, Hafner K, Jenkins RB, Libra M, Ingle J, Stivala F, Galanis E, Salisbury JL.

Int J Oncol. 2010 Nov;37(5):1167-76.

PMID:
20878064
[PubMed - indexed for MEDLINE]
19.

Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis.

Lemieux E, Bergeron S, Durand V, Asselin C, Saucier C, Rivard N.

Int J Cancer. 2009 Oct 1;125(7):1575-86. doi: 10.1002/ijc.24485.

PMID:
19462441
[PubMed - indexed for MEDLINE]
20.

Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells.

Li QQ, Xu JD, Wang WJ, Cao XX, Chen Q, Tang F, Chen ZQ, Liu XP, Xu ZD.

Clin Cancer Res. 2009 Apr 15;15(8):2657-65. doi: 10.1158/1078-0432.CCR-08-2372. Epub 2009 Mar 31.

PMID:
19336515
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk